• RANKING COUNTRIES BY QUALITY-ADJUSTED LIFE EXPECTANCY, MEDICAL EXPENDITURES, AND COST EFFECTIVENESS

    May 1, 2016, 00:00
  • AGE AND GENDER DISTRIBUTION OF OUTPATIENT CARE PHYSIOTHERAPY SERVICES FOR ELBOW AND FOREARM INJURIES IN HUNGARY

    May 1, 2016, 00:00
  • Sensitivity of Clinical Endpoints in the Asco Oncology Value Framework and Implications for Clinical Trial Design

    May 1, 2016, 00:00
  • PHARMACIST-PERCEIVED BARRIERS TO PROVIDING PATIENT CARE SERVICES- A SYSTEMATIC REVIEW

    May 1, 2016, 00:00
  • EVALUATING THE LONG-TERM OUTCOMES OF LIPOSOME BUPIVACAINE INJECTABLE SUSPENSION IN THE MANAGEMENT OF TOTAL KNEE ARTHROPLASTY PATIENTS

    May 1, 2016, 00:00
  • Knowledge, Attitudes, And Practice Towards Use of Long-Term Family Planning Methods Among Women Aged 15-49 Years- A Community-Based Survey in an Urban Ugandan Setting

    May 1, 2016, 00:00
  • OUTCOME ASSESSMENTS OF PRIMARY ENDPOINTS OF NEW DRUGS APPROVED BY THE FDA (2011-2015)

    May 1, 2016, 00:00
  • Improving Access for Surgical Patients using Various Policies

    May 1, 2016, 00:00
  • The Future Of HTA In Evolving Health Care Systems- Developing HTA Strategy For The United Arab Emirates

    May 1, 2016, 00:00
  • ESTIMATION OF TRANSITION PROBABILITIES BETWEEN CERVICAL LESIONS FOR THE NATURAL HISTORY OF CERVICAL CANCER AMONG CHINESE WOMEN

    May 1, 2016, 00:00
  • Exploring Issues In Analyzing National Databases Using Logistic Regression- Application Of Medical Expenditure Panel Survey

    May 1, 2016, 00:00
  • INSULIN INITIATION FOR TYPE 2 DIABETES MELLITUS IN CHINA- PHYSICIANS’ PREFERRED HBA1C LEVEL AT INSULIN INITIATION AND PATIENTS’ OBSERVED LEVELS

    May 1, 2016, 00:00
  • ASSESSMENT OF HEALTH-RELATED QUALITY OF LIFE WITH THE HEALTH ASSESSMENT QUESTIONNAIRE (HAQ) IN ARTHRITIS PATIENTS IN QUETTA PAKISTAN

    May 1, 2016, 00:00
  • Forecasting Treatment Costs of Follicular Lymphoma- A Population-Based Discrete Event Simulation

    May 1, 2016, 00:00
  • Treatment Patterns In Medicaid Beneficiaries With Schizophrenia Reaching Stabilized Maintenance With Once-Monthly Paliperidone Palmitate Therapy

    May 1, 2016, 00:00
  • SUSCEPTIBILITY PROFILE OF CLINICAL ISOLATES OF ESCHERICHIA COLI TO THIRD-GENERATION CEPHALOSPORINS

    May 1, 2016, 00:00
  • The Association Between Serum Uric Acid Levels and Acute Myocardial Infarction in Incident Gout Patients

    May 1, 2016, 00:00
  • EFFECTIVENESS OF 8 OR 12 WEEK LDV/SOF IN TREATMENT-NAÏVE PATIENTS WITH NON-CIRRHOTIC, GENOTYPE 1 HEPATITIS C- REAL-WORLD EXPERIENCE FROM THE TRIO NETWORK

    May 1, 2016, 00:00
  • GLYCEMIC CONTROL IN PATIENTS WITH TYPE 2 DIABETES TREATED WITH ONCE-WEEKLY GLP-1RAS- COMPARISON OF A NETWORK META-ANALYSIS WITH A DIRECT ANALYSIS OF PLACEBO-CONTROLLED TRIALS

    May 1, 2016, 00:00
  • PATIENT CHARACTERISTICS, HEALTH OUTCOMES, AND PREDICTORS OF ORGAN FAILURE OR REJECTION OF ORGAN TRANSPLANT RECIPIENTS IN THE UNITED STATES

    May 1, 2016, 00:00
  • CLINICAL AND ECONOMIC BURDEN OF EARLY VERSUS LATE INITIATION OF BRANDED CELECOXIB AMONG PATIENTS WITH OSTEOARTHRITIS

    May 1, 2016, 00:00
  • Potential Cost Savings Of Having Access To Antipsychotic Plasma Levels At The Point Of Care For Patients With Schizophrenia

    May 1, 2016, 00:00
  • Measuring The Economic Impact Of Ssb Taxes In Brazil- An Input-Output Analysis

    May 1, 2016, 00:00
  • Feasibility of Linking Benefit Design and Administrative Claims Data to Evaluate the Impact of Medication Access and Restrictive Formularies Across Multiple Therapeutic Areas

    May 1, 2016, 00:00
  • Predictors Of Electronic Cigarette Use Among Individuals With Asthma

    May 1, 2016, 00:00
  • Comparison Of Cardiovascular Risks Following Smoking Cessation Treatments Using Varenicline Versus Nrt Among Schizophrenic Smokers

    May 1, 2016, 00:00
  • Potential Drug-Drug Interactions in Pediatric Wards of Gondar University Hospital, Ethiopia- A Cross Sectional Study

    May 1, 2016, 00:00
  • Hypertrophic Cardiomyopathy- A Heart Burden and Challenging Diagnosis

    May 1, 2016, 00:00
  • Identifying Non-Responders to Brace Therapies in Multiple Sclerosis using Advanced Predictive Models

    May 1, 2016, 00:00
  • The Burden Of Atopic Dermatitis In Adults- Results From The 2013 United States National Health And Wellness Survey (Nhws)

    May 1, 2016, 00:00
  • Economic Evaluation of School-Based Health Centers- A Community Guide Systematic Review

    May 1, 2016, 00:00
  • Development and Implementation of the Medical Audit Process in Health Services at the First Level of Care- A Contextualized Model Adapted to Ecuador

    May 1, 2016, 00:00
  • PATIENT-LED RESEARCH- CHARACTERIZING USE OF A NOVEL MEDICAL RECORD TECHNOLOGY AMONGST AN INFLAMMATORY BOWEL DISEASE COHORT

    May 1, 2016, 00:00
  • SYSTEMATIC REVIEW OF ECONOMIC EVALUATIONS OF ALTERNATE IMMUNIZATION STRATEGIES TO CONTROL MENINGOCOCCAL MENINGITIS

    May 1, 2016, 00:00
  • A Cross-Sectional Survey of Community Pharmacists towards Antimicrobial Stewardship in Malaysia

    May 1, 2016, 00:00
  • Applications Of The Fda Guidance On Common Issues In Drug Development For Rare Diseases

    May 1, 2016, 00:00
  • CHANGES IN THE INCOME OF HEALTH CARE PROFESSIONAL IN HUNGARY

    May 1, 2016, 00:00
  • B.E.S.T. Asthma Program (Breathe easy. Start today.®)- A Primary Care-Based Program For Dispensing Asthma Medication and Devices Reduces Acute Hospitalization and Expenditures in Medicaid Subjects

    May 1, 2016, 00:00
  • Determinants And Distribution Of 18-24 Year Old Current Waterpipe Tobacco Smokers In The United States- Findings From The National Adult Tobacco Surveys

    May 1, 2016, 00:00
  • EFFICACY, SAFETY, AND COST-EFFECTIVENESS OF 13-VALENT PNEUMOCOCCAL VACCINE- OVERVIEW OF THE LITERATURE FOR INCORPORATION PURPOSES

    May 1, 2016, 00:00
  • Economic Evaluation Of Antipsychotics For The Treatment Of Schizophrenia- A Systematic Review

    May 1, 2016, 00:00
  • SYSTEMATIC REVIEW OF EFFICACY AND SAFETY OF DULAGLUTIDE COMPARED WITH OTHER ANTIDIABETIC DRUGS

    May 1, 2016, 00:00
  • SF6D VALUE SETS- A SYSTEMATIC REVIEW

    May 1, 2016, 00:00
  • BUDGET IMPACT MODEL FOR SELEXIPAG- TAKING A US PAYER PERSPECTIVE

    May 1, 2016, 00:00
  • HOW DO FORMULARY RESTRICTIONS AFFECT MEDICATION USE AND COSTS FOR LOW-INCOME SUBSIDY RECIPIENTS IN MEDICARE PART D PLANS?

    May 1, 2016, 00:00
  • THE UPTAKE OF BIOSIMILAR INFLIXIMAB BY ENGLISH ACUTE TRUSTS

    May 1, 2016, 00:00
  • THE WAY OF LIFE, IN PARTICULAR THE IMPACT OF STRESS IN EMERGENCE OF GASTROINTESTINAL COMPLAINTS

    May 1, 2016, 00:00
  • Checklist To Assess The Feasibility Of A Network Meta-Analysis

    May 1, 2016, 00:00
  • Selection Of The Most Appropriate Epro Mode- Contributing To The Success Of Patient-Centered Clinical Trials

    May 1, 2016, 00:00
  • DIETARY SUPPLEMENT USE, KNOWLEDGE, AND PERCEPTIONS AMONGST PHARMACY STUDENTS

    May 1, 2016, 00:00
  • Estimating the Arthroplasties Revision Rates and Lifetime of Knee and Hip Prosthesis in the State of São Paulo, Brazil

    May 1, 2016, 00:00
  • Natural Language Processing-Identified Problem Opioid Use And Its Associated Health Care Costs

    May 1, 2016, 00:00
  • Government Reimbursement Values versus Real Chemotherapy Costs in the Brazilian Public Health Care System- Another Barrier to Treatment Access?

    May 1, 2016, 00:00
  • The Relationship between Preventive Care Visits and School Absences among Children with Asthma

    May 1, 2016, 00:00
  • Health Care Costs among Men with Clinically Localized Prostate Cancer Managed with Observation Strategies Versus Immediate Treatment in an Integreated Health Care System

    May 1, 2016, 00:00
  • Examining Health-Related Productivity Losses due To Uterine Fibroids in the United States Using the Health-Related Productivity Questionnaire

    May 1, 2016, 00:00
  • ECONOMIC BURDEN OF MANAGING HYPERGLYCEMIA IN ACROMEGALIC PATIENTS WHO WERE DIABETIC AT BASELINE TREATED WITH PASIREOTIDE

    May 1, 2016, 00:00
  • FACTORS AFFECTING ADOPTION OF COMPUTERIZED PHYSICIAN ORDER ENTRY SYSTEM

    May 1, 2016, 00:00
  • COST BURDEN OF VENOUS THROMBOEMBOLISM AND ITS PROPHYLAXIS IN THE UNITED STATES

    May 1, 2016, 00:00
  • Depression Treatment and Health-Related Quality of Life Among Adults with Arthritis and Depression in the United States

    May 1, 2016, 00:00
  • Marketing Authorization of Medicines Approved In Eu Via “Adaptive Pathway”- Consequences on The Egyptian Public Health

    May 1, 2016, 00:00
  • Reducing Young Invincibles’ Health Care Spending through the Aca Expansion of Dependent Coverage

    May 1, 2016, 00:00
  • Comparative Effectiveness of Panitumumab Versus Cetuximab In Patients With Chemo-Refractory Wild-Type Kras Metastatic Colorectal Cancer

    May 1, 2016, 00:00
  • The Role of Patient-Reported Outcomes in Drug-Coverage Decisions for New Agents with Advanced Melanoma Indication

    May 1, 2016, 00:00
  • Predictors of Early Mortality in Patients with Second Hip Fracture

    May 1, 2016, 00:00
  • Treatment with interferon beta-1a in brazil is associated with fewer hospitalizations due to relapse, better adherence and a better response compared to other platform therapies

    May 1, 2016, 00:00
  • Impact of Disease Progression on Patient Reported Outcomes in Advanced Nsclc- Evidence from Patients Treated in Real World Community Oncology Settings

    May 1, 2016, 00:00
  • ECONOMIC EVALUATION OF ERTAPENEM IN THE TREATMENT OF SEPSIS FROM ENTEROBACTERIA PRODUCING BETA-LACTAMASES OF EXTENDED SPECTRUM (BLEES) AT THE MEXICO CHILDREN’S HOSPITAL “FEDERICO GOMEZ”

    May 1, 2016, 00:00
  • A Comparison of EQ-5D-3L and SF-6D Among Caregivers of Individuals with Multiple Sclerosis

    May 1, 2016, 00:00
  • EXTERNAL VALIDATION OF HEALTH ECONOMIC MODELS FOR COMPLEX CHRONIC DISEASES- LESSONS FROM A POPULATION MODEL FOR DIABETIC RETINOPATHYHerring W., Mladsi D.M. , RTI Health Solutions, Research Triangle Park, NC, USA

    May 1, 2016, 00:00
  • THE COST EFFECTIVENESS OF BARIATRIC TREATMENTS IN OVERWEIGHT AND OBESE PATIENTS

    May 1, 2016, 00:00
  • THE REAL-WORLD PAIN EXPERIENCE OF ADULTS WITH RHEUMATOID ARTHRITIS USING A MOBILE SURVEY

    May 1, 2016, 00:00
  • Development Of An Innovative Observational Study To Assess Multiple Sclerosis Disease Progression In Real World Clinical Practice

    May 1, 2016, 00:00
  • Cost-Utility Analysis of Intramuscular Interferon Beta-1b Versus Subcutaneous Interferon Beta-1b and Beta-1a in Patients with Relapsing-Remitting Multiple Sclerosis in Colombia

    May 1, 2016, 00:00
  • Trends In The Use Of Matching-Adjusted Indirect Comparisons In Published Literature And Nice Technology Assessments- A Systematic Review

    May 1, 2016, 00:00
  • DIRECT OUT OF POCKET EXPENDITURE FOR MEDICAL CARE OF TYPE 1 DIABETIC PATIENTS ATTENDING A TERTIARY CARE HOSPITAL

    May 1, 2016, 00:00
  • BUDGET IMPACT ANALYSIS OF RETINAL PROSTHESIS IN RETINITIS PIGMENTOSA PATIENTS

    May 1, 2016, 00:00
  • PSYCHOMETRIC EVALUATION OF THE FUNCTIONAL ASSESSMENT OF CANCER THERAPY–ANEMIA (FACT-AN) IN DIALYSIS AND NON-DIALYSIS PATIENTS WITH ANEMIA ASSOCIATED WITH CHRONIC KIDNEY DISEASE

    May 1, 2016, 00:00
  • OPTIMIZATION OF THE GENERAL SURGERY SERVICE OF THE UNIVERSITY HOSPITAL PEDRO ERNESTO

    May 1, 2016, 00:00
  • Impact of Dry Eye Disease on Quality of Life, Work Productivity, Daily Activities, and Health Care Resource Use in a Survey of 74,095 American Adults

    May 1, 2016, 00:00
  • The Burden Of Cystic Fibrosis- Pulmonary Exacerbations And Health Care Resource Utilization In A Commercially Insured Population In The United States

    May 1, 2016, 00:00
  • Real-World use of Secukinumab Among Patients with Psoriasis- Patient Characteristics and Dosing

    May 1, 2016, 00:00
  • EXPLORING THE COST-EFFECTIVE THRESHOLD PRICE OF DENGUE VACCINATION PROGRAMS IN MALAYSIA- A VALUE-BASED PRICING ASSESSMENT

    May 1, 2016, 00:00
  • CHARACTERIZATION OF MALE AND FEMALE USERS OF TESTOSTERONE AMONG THE COMMERCIALLY INSURED POPULATION IN THE UNITED STATES

    May 1, 2016, 00:00
  • Levodopa/Carbidopa Intestinal Gel Treatment and Its Impact on Quality of Life and Work Ability in Patients with Parkinson’s Disease in Czech Republic

    May 1, 2016, 00:00
  • ECONOMIC IMPACT OF MULTI-MORBIDITY IN COMMUNITY-ACQUIRED PNEUMONIA- EXPERIENCE IN ARGENTINA

    May 1, 2016, 00:00
  • THE EVOLUTION OF PRIVATE HEALTH INSURANCE IN EGYPT WITHIN THE IMPLEMENTATION OF UNIVERSAL HEALTH COVERAGE

    May 1, 2016, 00:00
  • Profiles of Performance of Health Service Providers to Implement a Pay-For-Performance Mechanism- Simulation Approach

    May 1, 2016, 00:00
  • Evaluation of Progression-Free Survival as a Surrogate Endpoint for Overall Survival in Metastatic Breast Cancer- Systematic Review and Trial Level Meta-Analysis

    May 1, 2016, 00:00
  • A Review Evaluating the Validity of Smartphone Sensors and Components to Measure Clinical Outcomes in Clinical Research

    May 1, 2016, 00:00
  • Oncology Drugs Lag Between Europe and other Countries- Comparaison between EMA and others Agencies (FDA, Health Canada, TGA, and Swissmedic)

    May 1, 2016, 00:00
  • Development and Validation of Patient Decision Aid for Antidepressant Medications

    May 1, 2016, 00:00
  • Evaluating Asthma-Related Expenses And Health Care Resource Utilization Among Children In The United States Medicaid Population

    May 1, 2016, 00:00
  • Value of Innovation in Oncology Treatments for Patients in Sweden with Advanced or Metastatic Non-Small Cell Lung Cancer

    May 1, 2016, 00:00
  • Comparing the Expanded Disability Status Scale Versus the Multiple Sclerosis Functional Composite As Clinical Endpoints in Multiple Sclerosis Clinical Trials- A Quantitative Meta-Analysis

    May 1, 2016, 00:00
  • Systematic Review of Clinical and Economic Outcomes Related to Surgical Site Infections in Latin America

    May 1, 2016, 00:00
  • EVALUATION OF BRAZILIAN CLINICAL GUIDELINES PRODUCED BY THE MINISTRY OF HEALTH IN RELATION TO THE AGREE II CRITERIA

    May 1, 2016, 00:00
  • Dealing With Uncertainty And Accounting For Social Value Judgments In Value Assessments For Orphan Drugs- Qualitative Evidence From Four European Countries

    May 1, 2016, 00:00
  • Comparative Efficacy And Tolerability Of Lurasidone For The Management Of Bipolar Depression- A Systematic Review And Network Meta-Analysis

    May 1, 2016, 00:00
  • Frequentist and Bayesian Meta-Analysis of Risk Factors for Respiratory Syncytial Virus Hospitalization in Preterm Infants

    May 1, 2016, 00:00
  • Impact of Depression on Health Expenses and Medical Utilization in Adults with Migraine

    May 1, 2016, 00:00
  • Comparing the Value of Evidence Over Time for Clopidogrel Pharmacogenomics Versus Drug-Drug Interactions

    May 1, 2016, 00:00
  • CLINICIAN ENGAGEMENT IN THE NIH HEALTH CARE SYSTEMS RESEARCH COLLABORATORY

    May 1, 2016, 00:00
  • Can indirect comparison methods mitigate evolving trial populations in adjunctive antiepileptic drug trials? A propensity-score matched indirect comparison of brivaracetam and levetiracetam

    May 1, 2016, 00:00
  • Reevaluating the Value of Ezetimibe in the United States For Patients with History of Cvd Based on the Improve-It Result

    May 1, 2016, 00:00
  • Validation of A Cost-Effectiveness Model Comparing Accuracy of Genetic Tests For Brca Mutations

    May 1, 2016, 00:00
  • EVALUATION OF THE PSYCHOMETRIC PROPERTIES OF TWO ELECTRONIC DAILY DIARIES DEVELOPED TO ASSESS BREAST PAIN/TENDERNESS AND VAGINAL BLEEDING/SPOTTING IN POSTMENOPAUSAL WOMEN ON HORMONE THERAPY

    May 1, 2016, 00:00
  • The Costs Of Cessation Medications Among Private Health Plans- An Environmental Scan Before The Enactment Of The Affordable Care Act

    May 1, 2016, 00:00
  • Emergency Department Visits Associated With Ankle Sprains In The United States

    May 1, 2016, 00:00
  • Current Literature Describing the Clinical Utility and Economic Value of Cancer Molecular Diagnostics

    May 1, 2016, 00:00
  • Assesment of the Medical and Social Benefits of Incretin-Based Therapy

    May 1, 2016, 00:00
  • Estimation Of Direct And Indirect Costs Associated With Asthma And Copd- A Canadian Employers Perspective

    May 1, 2016, 00:00
  • Revisiting The Performance Of Continuity Correction Methods In Meta-Analysis Of Sparse Data

    May 1, 2016, 00:00
  • AN ASSESSMENT OF THE VALIDITY AND RESPONSIVENESS OF THE ICECAP-O IN A MULTICENTRE RANDOMIZED CONTROLLED TRIAL OF BLOOD PRESSURE MANAGEMENT

    May 1, 2016, 00:00
  • Determining the Value of a Health System/School Partnership to Provide School Health and Pediatric Care in School- A Cost-Benefit Analysis

    May 1, 2016, 00:00
  • CLINICAL AND ECONOMIC OUTCOMES OF FIBRIN SEALANTS (EVICEL AND TISSEEL) USED FOR HEMOSTASIS IN CORONARY ARTERY BYPASS GRAFTING SURGERY IN THE UNITED STATES

    May 1, 2016, 00:00
  • Barriers and Facilitators to Diabetes Self-Management in a Primary Care Setting- Patient Perspective

    May 1, 2016, 00:00
  • The Concentration of Health Care Expenditure of a Colombian Public Health Insurance Company

    May 1, 2016, 00:00
  • ENCOURAGING SOCIAL PARTICIPATION IN BRAZILIAN HEALTH TECHNOLOGY ASSESSMENT

    May 1, 2016, 00:00
  • Knowledge and Practices Related to Rational Use of Antibiotics in Panama

    May 1, 2016, 00:00
  • Comparative-Effectiveness Analysis of Uterusconserving Procedures for Uterine Fibroids Using a Linked Electronic Medical Record Claims Database

    May 1, 2016, 00:00
  • Long-Term Cost Effectiveness Analysis Of Ideglira Versus Glp-1 Added To Basal Insulin As Intensification Therapies In Type 2 Diabetes Mellitus In Spain

    May 1, 2016, 00:00
  • Assessment of Disease-State Knowledge in Hypertensive Patients in Quetta, Pakistan

    May 1, 2016, 00:00
  • Patient Preference for Display of Electronic Patient-Reported Outcomes- Wording Emphasis, Question Format, and Navigation Button Placement

    May 1, 2016, 00:00
  • TRENDS AND UTILIZATION OF REAL-WORLD EVIDENCE-BASED INFORMATION TO SUPPORT MARKET ACCESS IN THE UNITED STATES

    May 1, 2016, 00:00
  • Unlocking Smartphone Potential in Health Care by Providing Smartphones to Patients- A Systematic Review

    May 1, 2016, 00:00
  • Overall Survival, Health-Related Quality of Life, and Healthcare Resource Use- Independent Analyses from Checkmate 025, A Phase Iii Study of Nivolumab Versus Everolimus in Patients with Advanced or Metastatic Clear-Cell Renal Cell Carcinoma ...

    May 1, 2016, 00:00
  • Examining Length of Stay and Home Discharge when Using Bupivacaine Liposomal Injectable Suspension in Medicare Patients Undergoing Total Hip Arthroplasty

    May 1, 2016, 00:00
  • Clinical Utility of Early Multigene Genetic Testing In Pediatric Patients With Suspected Seizure Disorders And Syndromic Epilepsies

    May 1, 2016, 00:00
  • Indirect Treatment Comparison Of Cabazitaxel For Patients With Metastatic Castration-Resistant Prostate Cancer Who Have Been Previously Treated With A Docetaxel-Containing Regimen

    May 1, 2016, 00:00
  • THE IMPACT OF HYPOGLYCAEMIA ON PATIENT ACTIONS AND QUALITY OF LIFE IN 5 EUROPEAN COUNTRIES

    May 1, 2016, 00:00
  • ANALYSIS OF TRENDS IN UTILIZATION AND COST OF INSULIN IN THE UNITED STATES AND CANADA

    May 1, 2016, 00:00
  • PARAMETERIZATION OF A DISEASE PROGRESSION SIMULATION MODEL FOR SEQUENTIALLY TREATED METASTATIC HER2-POSITIVE BREAST CANCER PATIENTS

    May 1, 2016, 00:00
  • Caregiver Burden In The United States Workfor Health Care Resource Utilization And Quality of Life

    May 1, 2016, 00:00
  • Relative Value Assessment- Characterizing the Benefit of Oncology Therapies Through Diverse Metrics

    May 1, 2016, 00:00
  • ESTIMATION OF HEALTH BENEFITS FROM SUCCESSFUL PREVENTION OF AN ILLNESS- METHODS AND EXAMPLES

    May 1, 2016, 00:00
  • Evaluate the Quality of Life of Patient with Chronic Myeloid Leukemia in Vietnam

    May 1, 2016, 00:00
  • COST-EFFECTIVENESS OF ATAZANAVIR/RITONAVIR AGAINST LOPINAVIR/RITONAVIR IN THE TREATMENT OF PEOPLE LIVING WITH HIV IN PERU

    May 1, 2016, 00:00
  • An Analysis Of The Criteria Used In Existing Or Proposed Mcda Models

    May 1, 2016, 00:00
  • DEVELOPMENT OF THE IMPACT OF OPIOID ON BIOPYSCHOSOCIAL-SPIRITUAL FUNCTIONS (IOBPSS) SCALE IN ACUTE AND CHRONIC PAIN

    May 1, 2016, 00:00
  • A PILOT STUDY TO ASSESS THE EFFICACY AND SAFETY OF FOLIC ACID AND/OR VITAMIN B COMPLEX ON HEPATITIS C INFECTED PATIENTS TREATED WITH PEGYLATED INTERFERON AND RIBAVIRIN

    May 1, 2016, 00:00
  • ESTIMATING HOSPITAL COSTS FOR MEDICARE PATIENTS UNDERGOING TOTAL KNEE ARTHROPLASTY USING PREMIER CHARGEMASTER DATA

    May 1, 2016, 00:00
  • Measuring Treatment Satisfaction in Erectile Dysfunction- Use of A Person-Item Map

    May 1, 2016, 00:00
  • Types of Chronic Conditions Combinations and Initial Cancer Treatment among Elderly Medicare Beneficiaries with Localized Prostate Cancer

    May 1, 2016, 00:00
  • Assessing the Value of Treatment to Address Various Symptoms Associated with Multiple Sclerosis

    May 1, 2016, 00:00
  • Retrospective Chart Review Study to Evaluate Health Care Resource Utilization in Patients with Symptomatic Multiple Myeloma in Italy

    May 1, 2016, 00:00
  • Demographic and Socioeconomic Characteristics that Impact Selection of Oral Anticoagulants Among Non-Valvular Atrial Fibrillation Patients

    May 1, 2016, 00:00
  • Evaluation of Asthma Outcomes in Older and Younger Adults

    May 1, 2016, 00:00
  • Humanistic Burden After Renaltransplantation In Europe- Systematic Literature Review

    May 1, 2016, 00:00
  • Comparative Estimation of the Out-of-Pocket Expenses and Indirect Costs Associated Ovarian Cancer and Parkinson’s Disease

    May 1, 2016, 00:00
  • Psychiatric Safety Profile Of Suvorexant, A First-In-Class Orexin Receptor Antagonist

    May 1, 2016, 00:00
  • Awareness and Impact of International Normalized Ratio Monitoring in Ongoing Anticoagulation Therapy in Cardiac Patients

    May 1, 2016, 00:00
  • HTA IN BRAZIL- WHAT HAS CHANGED SINCE THE CREATION OF CONITEC?

    May 1, 2016, 00:00
  • A Prevalence Study on Gestational Hypertension and Associated Complications in Pregnant Women

    May 1, 2016, 00:00
  • Associated Factors with Graft Loss in Kidney Transplantation Patients who used Maintenance Immunosuppressive Regimens Containing Cyclosporine or Tacrolimus in Sus

    May 1, 2016, 00:00
  • Model Observational Bridging Study on the Effectiveness of Ezetimibe on Cardiovascular Outcomes

    May 1, 2016, 00:00
  • PCPA/CDR/PCODR CHANGES AND IMPACT TO MARKET ACCESS IN CANADA

    May 1, 2016, 00:00
  • COST-EFFECTIVENESS ANALYSIS OF DULAGLUTIDE COMPARED WITH INSULIN GLARGINE ADD ON TO INSULIN LISPRO IN TREATMENT OF TYPE 2 DIABETES- A US THIRD-PARTY PAYER PERSPECTIVE

    May 1, 2016, 00:00
  • Evaluation of the Cost Effectiveness of the Treatment of Mild and Moderate Alzheimer’s Disease in Brazil

    May 1, 2016, 00:00
  • Oncologic Outcomes Of Metformin In Patients With Non-Metastatic Colon Cancer And Type 2 Diabetes In South Korea Using Nationwide Database

    May 1, 2016, 00:00
  • A Cost-Effectiveness Analysis of Palbociclib and other Aromatase Inhibitors for Treatment of Advanced Breast Cancer

    May 1, 2016, 00:00
  • Impact of Bupivacaine Liposomal Injectable Suspension on Hospital Length of Stay and Home Discharge among Medicare Patients Undergoing Total Knee Arthroplasty

    May 1, 2016, 00:00
  • Preferences For Pediatric Attention-Deficit/Hyperactivity Disorder Management And Medication Changes And Caregiver-Reported Improvement Over A 6-Month Follow-Up

    May 1, 2016, 00:00
  • Demographic Variance of Inpatient Hospitalizations from Stroke in the State of Missouri from 2000-2012

    May 1, 2016, 00:00
  • IMPROVING THE CLINICAL PRACTICE GUIDELINES- WHY INCLUDE PSYCHOLOGICAL EVALUATION AND INTERVENTION?

    May 1, 2016, 00:00
  • DEVELOPING GUIDELINES FOR MIGRATING THE ACTS, A PAPER PRO, TO WEB FORMAT

    May 1, 2016, 00:00
  • Health Care Inequality And Business Cycles In Japan

    May 1, 2016, 00:00
  • Table of Contents

    May 1, 2016, 00:00
  • A Study To Determine The Economic Impact Of Major Depressive Disorder In Colombia

    May 1, 2016, 00:00
  • Cost Analysis Of Patients With Multiple Sclerosis Newly Initiating Subcutaneous Interferon β-1a Versus Oral Disease-Modifying Drugs

    May 1, 2016, 00:00
  • MARKET ACCESS AND PRICING ANALYSIS OF ULTRA-ORPHAN DRUGS

    May 1, 2016, 00:00
  • Challenges in Using MCDA for Reimbursement Decisions on New Medicines?

    Mar 1, 2016, 00:00
  • Systematic Review of Economic Evaluations of Units Dedicated to Acute Coronary Syndromes

    Mar 1, 2016, 00:00
  • Multiple Criteria Decision Analysis for Health Care Decision Making—Emerging Good Practices- Report 2 of the ISPOR MCDA Emerging Good Practices Task Force

    Mar 1, 2016, 00:00
  • Patient-Centered Outcomes of Medication Adherence Interventions- Systematic Review and Meta-Analysis

    Mar 1, 2016, 00:00
  • Copyright/Subscription

    Mar 1, 2016, 00:00
  • Estimating the Cost-Effectiveness of Implementation- Is Sufficient Evidence Available?

    Mar 1, 2016, 00:00
  • Erratum

    Mar 1, 2016, 00:00
  • Instructions for Authors

    Mar 1, 2016, 00:00
  • Examining the Value of Menopausal Symptom Relief Among US Women

    Mar 1, 2016, 00:00
  • Methods Used in Economic Evaluations of Tuberculin Skin Tests and Interferon Gamma Release Assays for the Screening of Latent Tuberculosis Infection- A Systematic Review

    Mar 1, 2016, 00:00
  • The Cost-Effectiveness of Prostate Cancer Detection with the Use of Prostate Health Index

    Mar 1, 2016, 00:00
  • Sources and Characteristics of Utility Weights for Economic Evaluation of Pediatric Vaccines- A Systematic Review

    Mar 1, 2016, 00:00
  • Valuing Health Using Time Trade-Off and Discrete Choice Experiment Methods- Does Dimension Order Impact on Health State Values?

    Mar 1, 2016, 00:00
  • Improving Adherence to Cardiovascular Therapies- An Economic Evaluation of a Randomized Pragmatic Trial

    Mar 1, 2016, 00:00
  • Cost-Effectiveness of Incobotulinumtoxin-A with Flexible Treatment Intervals Compared to Onabotulinumtoxin-A in the Management of Blepharospasm and Cervical Dystonia

    Mar 1, 2016, 00:00
  • Preferences for Prostate Cancer Outcomes- A Comparison of the Patient Perspective, the General Population Perspective, and a Population at Risk for Prostate Cancer

    Mar 1, 2016, 00:00
  • Responsiveness to Change in PROMIS Pediatric Asthma Study

    Mar 1, 2016, 00:00
  • Comprehensively Measuring Health-Related Subjective Well-Being- Dimensionality Analysis for Improved Outcome Assessment in Health Economics

    Mar 1, 2016, 00:00
  • The Use of Economic Evidence to Inform Drug Pricing Decisions in Jordan

    Mar 1, 2016, 00:00
  • Valuing Treatments for Parkinson Disease Incorporating Process Utility- Performance of Best-Worst Scaling, Time Trade-Off, and Visual Analogue Scales

    Mar 1, 2016, 00:00
  • Table of Contents

    Mar 1, 2016, 00:00
  • Cost-Effectiveness of a Collaborative Care Depression and Anxiety Treatment Program in Patients with Acute Cardiac Illness

    Mar 1, 2016, 00:00
  • Survival or Mortality- Does Risk Attribute Framing Influence Decision-Making Behavior in a Discrete Choice Experiment?

    Mar 1, 2016, 00:00
  • Evaluation of Resource Utilization and Treatment Patterns in Patients with Actinic Keratosis in the United States

    Mar 1, 2016, 00:00
  • Expanding Health Technology Assessments to Include Effects on the Environment

    Mar 1, 2016, 00:00
  • A Simple and Practical Index to Measure Dementia-Related Quality of Life

    Jan 1, 2016, 00:00
  • Copyright/Subscription

    Jan 1, 2016, 00:00
  • Impact of the 12-Gene Colon Cancer Assay on Clinical Decision Making for Adjuvant Therapy in Stage II Colon Cancer Patients

    Jan 1, 2016, 00:00
  • Instructions for Authors

    Jan 1, 2016, 00:00
  • Assessing Patient-Reported Outcomes in Pediatric Populations With Vaccine-Preventable Infectious Diseases- A Systematic Review of the Literature (the PROCHID Study)

    Jan 1, 2016, 00:00
  • Thirty Years of Media Coverage on High Drug Prices in the United States—A Never-Ending Story or a Time for Change?

    Jan 1, 2016, 00:00
  • Table of Contents

    Jan 1, 2016, 00:00
  • The Parity Paradigm- Can Legislation Help Reduce the Cost Burden of Oral Anticancer Medications?

    Jan 1, 2016, 00:00
  • New French Coverage with Evidence Development for Innovative Medical Devices- Improvements and Unresolved Issues

    Jan 1, 2016, 00:00
  • Do You Want to Hear the Bad News? The Value of Diagnostic Tests for Alzheimer’s Disease

    Jan 1, 2016, 00:00
  • The Reporting of Treatment Nonadherence and Its Associated Impact on Economic Evaluations Conducted Alongside Randomized Trials- A Systematic Review

    Jan 1, 2016, 00:00
  • Multiple Criteria Decision Analysis for Health Care Decision Making—An Introduction- Report 1 of the ISPOR MCDA Emerging Good Practices Task Force

    Jan 1, 2016, 00:00
  • Changes in Quality of Life Associated with Complications of Diabetes- Results from the ADVANCE Study

    Jan 1, 2016, 00:00
  • Cost-Effectiveness of Integrating a Clinical Decision Rule and Staged Imaging Protocol for Diagnosis of Appendicitis

    Jan 1, 2016, 00:00
  • Errata

    Jan 1, 2016, 00:00
  • The “Efficacy-Effectiveness Gap”- Historical Background and Current Conceptualization

    Jan 1, 2016, 00:00
  • The Cost of Increasing Physical Activity and Maintaining Weight for Midlife Sedentary African American Women

    Jan 1, 2016, 00:00
  • Concept Elicitation Within Patient-Powered Research Networks- A Feasibility Study in Chronic Lymphocytic Leukemia

    Jan 1, 2016, 00:00
  • An Empirical Study of Two Alternative Comparators for Use in Time Trade-Off Studies

    Jan 1, 2016, 00:00
  • Health-Related Quality of Life and Health Utilities in Metastatic Castrate-Resistant Prostate Cancer- A Survey Capturing Experiences from a Diverse Sample of UK Patients

    Dec 1, 2015, 00:00
  • Table of Contents

    Dec 1, 2015, 00:00
  • Using Decision-Analytic Modeling to Isolate Interventions That Are Feasible, Efficient and Optimal- An Application from the Norwegian Cervical Cancer Screening Program

    Dec 1, 2015, 00:00
  • Long-Term Efficacy of Etanercept for Plaque-Type Psoriasis and Estimated Cost in Daily Clinical Practice

    Dec 1, 2015, 00:00
  • Reliability and Validity of the Work Instability Scale for Rheumatoid Arthritis

    Dec 1, 2015, 00:00
  • Economic Evaluation of Cinacalcet in the United States- The EVOLVE Trial

    Dec 1, 2015, 00:00
  • A Quality-Adjusted Life-Year Measure for Multiple Sclerosis- Developing a Patient-Reported Health State Classification System for a Multiple Sclerosis-Specific Preference-Based Measure

    Dec 1, 2015, 00:00
  • Cost-Effectiveness Analysis of Universal Human Papillomavirus Vaccination Using a Dynamic Bayesian Methodology- The BEST II Study

    Dec 1, 2015, 00:00
  • Development of the Treatment Inventory of Costs in Psychiatric Patients- TIC-P Mini and Midi

    Dec 1, 2015, 00:00
  • Time Series Analysis on the Impact of Generic Substitution and Reference Pricing on Antipsychotic Costs in Finland

    Dec 1, 2015, 00:00
  • Health Utility Values Associated with Surgical Site Infection- A Systematic Review

    Dec 1, 2015, 00:00
  • A Vision “Bolt-On” Item Could Increase the Discriminatory Power of the EQ-5D Index Score

    Dec 1, 2015, 00:00
  • Beware of Kinked Frontiers- A Systematic Review of the Choice of Comparator Strategies in Cost-Effectiveness Analyses of Human Papillomavirus Testing in Cervical Screening

    Dec 1, 2015, 00:00
  • Comparison of Benefit-Risk Assessment Methods for Prospective Monitoring of Newly Marketed Drugs- A Simulation Study

    Dec 1, 2015, 00:00
  • Copyright/Subscription

    Dec 1, 2015, 00:00
  • HIV Treatment in Resource-Limited Environments- Treatment Coverage and Insights

    Dec 1, 2015, 00:00
  • Erratum

    Dec 1, 2015, 00:00
  • Prospective Benefit-Risk Monitoring of New Drugs for Rapid Assessment of Net Favorability in Electronic Health Care Data

    Dec 1, 2015, 00:00
  • Appropriateness of Prescriptions of Recommended Treatments in Organisation for Economic Co-operation and Development Health Systems- Findings Based on the Long-Term Registry of the European Society of Cardiology on Heart Failure

    Dec 1, 2015, 00:00
  • HIQA’s CEA of Breast Screening- Pragmatic Policy Recommendations are Welcome, but ACERs Reported as ICERs are Not

    Dec 1, 2015, 00:00
  • Estimating a Preference-Based Index for an Eight-Dimensional Health State Classification System for Multiple Sclerosis

    Dec 1, 2015, 00:00
  • Cost-Effectiveness of Chemotherapy for Breast Cancer and Age Effect in Older Women

    Dec 1, 2015, 00:00
  • Quality of Life and Asthma Symptom Control- Room for Improvement in Care and Measurement

    Dec 1, 2015, 00:00
  • Citizens’ Perspectives on Disinvestment from Publicly Funded Pathology Tests- A Deliberative Forum

    Dec 1, 2015, 00:00
  • The Suitability of End Point Designs for Health Technology Assessment in Chronic Pain Studies

    Dec 1, 2015, 00:00
  • Cost-Effectiveness of Disease Management Programs for Cardiovascular Risk and COPD in The Netherlands

    Dec 1, 2015, 00:00
  • Instructions for Authors

    Dec 1, 2015, 00:00
  • Impact and Cost-Effectiveness of Hypothetical Strategies to Enhance Retention in Care within HIV Treatment Programs in East Africa

    Dec 1, 2015, 00:00
  • Development and Content Validity Testing of a Patient-Reported Treatment Acceptance Measure for Use in Patients Receiving Treatment via Subcutaneous Injection

    Dec 1, 2015, 00:00
  • The Burden of Diabetes Mellitus in Patients with Coronary Heart Disease- A Methodological Approach to Assess Quality-Adjusted Life-Years Based on Individual-Level Longitudinal Survey Data

    Dec 1, 2015, 00:00
  • Using Generalized Linear Mixed Models to Evaluate Inconsistency within a Network Meta-Analysis

    Dec 1, 2015, 00:00
  • Cost-Effectiveness of Certolizumab Pegol for The Treatment of Axial Spondyloarthritis In Turkey

    Nov 1, 2015, 00:00
  • Relationship Between The Provision of Injection Services In Ambulatory Physician Offices And Prescribing Injectable Medicines In Iran

    Nov 1, 2015, 00:00
  • Social Burden of Chronic Hcv Infection in Patients with Hepatocellular Carcinoma

    Nov 1, 2015, 00:00
  • Assessment Of Knowledge And Awareness Regarding Asthma Among School Teachers In Quetta

    Nov 1, 2015, 00:00
  • Liste-En-Sus Reform In France - What are The Consequences?

    Nov 1, 2015, 00:00
  • Virtual Consultation System To Enable Rare Diseases Diagnosis

    Nov 1, 2015, 00:00
  • Healthcare Burden and Economic Cost of Hospitalisation During Chemotherapy for Adult Patients with Ph-Negative B-Precursor Relapsed or Refractory (R/R) Acute Lymphoblastic Leukaemia (All) in France

    Nov 1, 2015, 00:00
  • Acessibilidade De Obesos M”Rbidos Usuários Do Sistema Público De Saúde No Brasil

    Nov 1, 2015, 00:00
  • Evalución Económica Completa Del Sistema De Terapia De Radiación Con Rayos X Para El Tratamiento Cáncer De Próstata De Alto Riesgo En México

    Nov 1, 2015, 00:00
  • Cost-Effectiveness Analysis Of Bemiparin Used As Acute Treatment For Deep Venous Thrombosis Without Pulmonary Embolism

    Nov 1, 2015, 00:00
  • Cost-Effectiveness Analysis of Quadrivalent Influenza Vaccine in Spain

    Nov 1, 2015, 00:00
  • Assessing the Public Health Impact and Cost Effectiveness of Pneumococcal Vaccines for Adults 65 Years of Age in Colombia

    Nov 1, 2015, 00:00
  • Examining Health System And Resource Utilization And Medical Management Of Patients Idiopathic Pulmonary Fibrosis In Ontario- A Preliminary Analysis

    Nov 1, 2015, 00:00
  • Estimating The Public Health Impact Of A Vaccination Programme With A Nonavalent Hpv Vaccine In Germany

    Nov 1, 2015, 00:00
  • Economic Aspects in the Management of Diabetes in Italy

    Nov 1, 2015, 00:00
  • Cost-Effectiveness Of A 13-Valent Conjugate Pneumococcal Vaccination Program In Copd Patients Aged 50+ Years In Spain

    Nov 1, 2015, 00:00
  • TRANSLATION AND LINGUISTIC VALIDATION OF THE MODIFIED MYELOPROLIFERATIVE NEOPLASM SYMPTOM ASSESSMENT FORM - TOTAL SYMPTOM SCORE (MMPN-SAF TSS) FOR USE IN 26 COUNTRIES

    Nov 1, 2015, 00:00
  • Association of Treatment with Carvedilol, Bisoprolol and Metoprolol on the Risk of Mortality and Hospital Admission Among Older Adults with Heart Failure

    Nov 1, 2015, 00:00
  • Psychiatric Healthcare Utilization and Related Costs In Newly Diagnosed Individuals With Autism Spectrum Disorder (Asd) In Quebec (Canada)

    Nov 1, 2015, 00:00
  • Modelling Methods for Eq-5d – a Fitting Time for Change

    Nov 1, 2015, 00:00
  • Mapping the Beck Depression Inventory to the Eq-5d-3l in Patients with Depressive Disorders

    Nov 1, 2015, 00:00
  • Caracterización de Pacientes Con Múltiples Enfermedades Crónicas desde la Perspectiva Del Aseguramiento en Colombia

    Nov 1, 2015, 00:00
  • Cancer Drug Funding Decisions in the UK- Innovation And Value in the Biologics Era

    Nov 1, 2015, 00:00
  • Apheresis Treatment In German Patients With Severe Hypercholesterolemia - A Psychodrama Market Research

    Nov 1, 2015, 00:00
  • What is the Most Cost-Effective way to Set-Up Organised Cervical Cancer Screening in France? a Budget Impact Analysis

    Nov 1, 2015, 00:00
  • The Cost-Effectiveness (CE) of Intravitreal Aflibercept (IVT-AFL) in the Treatment of Diabetic Macular Edema (DME) in Turkey

    Nov 1, 2015, 00:00
  • Identification of Subgroups With Low Rates of Weight Loss In Israel

    Nov 1, 2015, 00:00
  • Out Hospital Drug Consumption in Therapy of Obstructive Pulmonary Disease in Serbia in the Period from 2007 to 2012

    Nov 1, 2015, 00:00
  • Bayesian Network Meta-Analysis To Assess The Comparative Efficacy And Safety Of Treatments For Severe Or Uncontrolled Asthma

    Nov 1, 2015, 00:00
  • The Epidemiological and Cost Burden of Herpes Zoster (Hz) and Post-Herpetic Neuralgia (Phn) in the Uk

    Nov 1, 2015, 00:00
  • Consequences Of Biomarker Analysis On The Cost-Effectiveness Of Cetuximab In Combination With Irinotecan Based Chemotherapy For First-Line Treatment Of Metastatic Colorectal Cancer. Stratified Medicine At Work?

    Nov 1, 2015, 00:00
  • New Nhi Reimbursement Coverage Paradigm Called ‘Selective Reimbursement Scheme’ On The Four Major Diseases In Korea

    Nov 1, 2015, 00:00
  • The Use of Indirect Comparisons in Medicines Evaluation for their Access To Reimbursement by the Has

    Nov 1, 2015, 00:00
  • Challenges to The Economic Modelling of Macular Oedema Due to Retinal Vein Occlusion And Diabetes

    Nov 1, 2015, 00:00
  • An Eq-5d-3l Value Set For Trinidad And Tobago

    Nov 1, 2015, 00:00
  • Cost-Effectiveness Analysis Of Granulocyte Colony-Stimulating Factors For The Prophylaxis Of Chemotherapy-Induced Febrile Neutropenia In Patients With Breast Cancer In Greece

    Nov 1, 2015, 00:00
  • Epidemiology and Current Treatment of Neuromyelitis Optica- A Systematic Review

    Nov 1, 2015, 00:00
  • Cost-Effectiveness of Esomeprazole Compared With Other Ppis Currently Reimbursed In Poland In The Treatment of Gerd

    Nov 1, 2015, 00:00
  • Assessment of Dental Status and Perception Towards Oral Health Among Pharmacy Students In Quetta, Pakistan

    Nov 1, 2015, 00:00
  • Quality Of Life In Adult Intradural Primary Spinal Cord Tumors- Short Form–36 Correlates With The Scales Of Mccormick And Aminoff-Logue

    Nov 1, 2015, 00:00
  • Costo De Cáncer De Colon Avanzado En Los Establecimientos Hospitalarios Del Perú

    Nov 1, 2015, 00:00
  • Defining Market Access in Brazil- the Pharma Professionals’ Perspective

    Nov 1, 2015, 00:00
  • The Relationship Between Knowledge and Performan The Case of Iran Community Pharmacies

    Nov 1, 2015, 00:00
  • Knowledge, Attitude And Practices Towards Medication Use Among Post-Graduate Pharmacy Students

    Nov 1, 2015, 00:00
  • Cost And Resource Utilization Of Uncontrolled And Persistent Asthma In Canada- A Systematic Literature Review

    Nov 1, 2015, 00:00
  • Economic and Clinical Impact of Secondhand Smoking In Korea

    Nov 1, 2015, 00:00
  • Identifying Practical Gaps to Comply with Cost-Effectiveness Guideline in Selecting Comparators in South Korea

    Nov 1, 2015, 00:00
  • Using Geographic Information Systems and Multi-Criteria Decision Analysis to Address Spatially Explicit Problems in Healthcare Policy Decision Making

    Nov 1, 2015, 00:00
  • Overview of Nub Process for In-Patient Drugs and Devices In German

    Nov 1, 2015, 00:00
  • Disease Progression In Rheumatoid Arthritis- Key Element for Cost-Effectiveness Modelling

    Nov 1, 2015, 00:00
  • Economic Impact of A Volumetric Infusion Pump (Infusomat® Space) + Central Alarm Management (One View), In The Risk Prevention In Infusion Therapy In The Intensive Care Unit (Icu) In Mexico

    Nov 1, 2015, 00:00
  • The Economic Impact of The use of Implantable Cardioverter Defibrillator In Primary Prevention

    Nov 1, 2015, 00:00
  • Study on Cost-Effectiveness Analysis For Ulcerative Colitis Treatment- A Systematic Review of Literature From 2004-2014

    Nov 1, 2015, 00:00
  • Development Of A Model To Provide Insight In The Value Of Fibrinogen Concentrate For Treating Excessive Bleedings During Complex Cardiovascular Surgery

    Nov 1, 2015, 00:00
  • Influence Of The Method Of Analysis On Estimates Of Qaly Treatment Differen Phase Iii Trial Of Vinflunine Versus Best Supportive Care In Patients With Tccu

    Nov 1, 2015, 00:00
  • The Use Of Real World Evidence (Rwe) To Investigate The Overall Treatment Effects Of Different Lines Of Therapy In Rheumatoid Arthritis

    Nov 1, 2015, 00:00
  • Impact of Healthcare Reforms on Pricing and Reimbursement In Turkey

    Nov 1, 2015, 00:00
  • Matching-Adjusted Indirect Treatment Comparison And Survival Extrapolation In Radioiodine-Refractory Differentiated Thyroid Cancer (Rai-Refractory Dtc)- Updated Analysis

    Nov 1, 2015, 00:00
  • Burden of Disease of Diabetes Mellitus Typ-2 In Austria

    Nov 1, 2015, 00:00
  • The Uk Pharmaceutical Price Regulation Scheme (Pprs) – Considerations of Voluntary Versus Statutory Regulations and How to Negotiate Pricing

    Nov 1, 2015, 00:00
  • Health-Related Quality Of Life (Hrqol) Benefits Of Enzalutamide In Patients With Metastatic Castration-Resistant Prostate Cancer (Mcrpc)- An In-Depth Analysis Of Eq-5d Data From The Prevail Trial

    Nov 1, 2015, 00:00
  • Utilização Do Escore De Propensão Na Comparação De Duas Opç’es Terapêuticas Em Pacientes Com Carcinoma Epiderm”Ide De Cabeça E Pescoço, Brasil 1998-2008

    Nov 1, 2015, 00:00
  • Direct Evidence Versus Lack of Direct Evidence and the Impact on HTA Acceptance

    Nov 1, 2015, 00:00
  • Qualitative Discussion on Issues of Patient-Reported Outcome Assessment in Post-Marketing Surveillance for Diseases in the Elderly

    Nov 1, 2015, 00:00
  • Health-Related Quality Of Life (Hrqol) Measures In Autosomal Dominant Polycystic Kidney Disease (Adpkd)

    Nov 1, 2015, 00:00
  • Prevention and Treatment of Missing Data in Real World Research

    Nov 1, 2015, 00:00
  • Market Access of Atmps- Overview and Expected Challenges

    Nov 1, 2015, 00:00
  • Epidemiology of Statin-Treated Patients with Uncontrolled Ldl Levels from Italian Administrative Official Databases

    Nov 1, 2015, 00:00
  • Economic Evaluation of Infliximab for Treatment of Refractory Ulcerative Colitis In Iran- Cost-Effectiveness Analysis

    Nov 1, 2015, 00:00
  • Budget Impact Analysis of The Use of Alteplase In The Treatment of Acute Ischaemic Stroke In Mexico

    Nov 1, 2015, 00:00
  • Evaluacion Sobre Medicamentos y Actos Medicos Cubiertos Financieramente Por Resolucion Judicial- Fnr

    Nov 1, 2015, 00:00
  • Relationship between Pain, Functional Disability and Health-Related Quality of Life in Patient with Failed Back Surgery Syndrome Undergoing Spinal Cord Stimulation- Results from the Precise Study

    Nov 1, 2015, 00:00
  • Estimacion Del Costo De Tratamiento De Un Evento Moderado Versus Uno Severo De Hipoglucemia En Pacientes Con Diabetes Mellitus Tipo 2 En Mexico Desde La Opinion De Expertos

    Nov 1, 2015, 00:00
  • Ranking of Disease-Modifying Therapies for Multiple Sclerosis

    Nov 1, 2015, 00:00
  • The Cost of Non-Severe Hypoglycaemia In Europe

    Nov 1, 2015, 00:00
  • The Relative Efficacy And Safety Of Treatments In Second-Line Management Of Chronic Myeloid Leukaemia- Systematic Review And Network Meta-Analysis Feasibility Study

    Nov 1, 2015, 00:00
  • The Importance of the Communicator for an Integrated Care Program - A Comparative Preference Analysis with Discrete Choice Experiments

    Nov 1, 2015, 00:00
  • Preliminary Study of Safety and Efficacy of Warfarin Versus Dabigatran in Atrial Fibrillation Patients in a Tertiary Hospital in Malaysia

    Nov 1, 2015, 00:00
  • Cost-Minimization For A Novel Ibs Diagnostic Blood Panel Versus Standard Exclusionary Diagnostic Testing For Diarrhea Predominant Irritable Bowel Syndrome- A United States Perspective

    Nov 1, 2015, 00:00
  • The Use Comparative Effectiveness Research And Evidence Based Medicine In Us Payor Decision Making

    Nov 1, 2015, 00:00
  • Reduction In C-Reactive Protein With Biologic Drugs In Rheumatoid Arthritis and Spondylitis Patients In German Rheumatologist Practices

    Nov 1, 2015, 00:00
  • Pangaea 2.0- State Of The Art Multiple Sclerosis Patient Management In Daily Clinical Practice. A New 3-Year Observational Study Of Patients Receiving Fingolimod

    Nov 1, 2015, 00:00
  • Recent Hypoglycemia Episodes Are Associated With Poorer Quality Of Life, Healthcare Resource Use, And Work Impairment Among Patients With Type II Diabetes In Brazil

    Nov 1, 2015, 00:00
  • Public Health Impact and cost-Effectiveness of Malaria routine Vaccination in Infants

    Nov 1, 2015, 00:00
  • A Study of Knowledge, Attitude And Practice of Community Pharmacists Towards Adverse Drug Reaction Reporting Monitoring

    Nov 1, 2015, 00:00
  • Cost-Effectiveness Of Deep Brain Stimulation (Dbs) In The Management Of Advanced Parkinson’s Disease- A Swedish Payer Perspective

    Nov 1, 2015, 00:00
  • Transparency and Reproducibility of Supplementary Search Methods in Nice Single Technology Appraisal Manufacturer Submissions

    Nov 1, 2015, 00:00
  • The Health And Medical Care Costs For Hospitalized All-Cause Pneumonia Among Children 2 Years, Pre And Postthe Introduction Of Prevenar13 In Sweden

    Nov 1, 2015, 00:00
  • Assessment of Compliance among Patients with Arthritis

    Nov 1, 2015, 00:00
  • Assessment of Effective Incentives for Blood Donations. How can citizens be Motivated to donate Blood?

    Nov 1, 2015, 00:00
  • Anaesthesia In Developing Countries

    Nov 1, 2015, 00:00
  • A Five-Year Model to Assess The Cost-Effectiveness of New Diagnostic Tests In The Early Diagnosis of Rheumatoid Arthritis

    Nov 1, 2015, 00:00
  • The Efficiency Path- An Estimation of Cost-Effectiveness Thresholds for 185 Countries Based on Per Capita Health Expenditures and Life Expectancy

    Nov 1, 2015, 00:00
  • ‘How Does that Make You feel?’ - the Ambiguity of Translating Depression

    Nov 1, 2015, 00:00
  • Comparison Of Kras Tested And Not-Tested Metastatic Colorectal Cancer (Mcrc) Patient Cohorts In Europe

    Nov 1, 2015, 00:00
  • Clinical Responses in Joint and Skin Outcomes and Patient-Reported Outcomes are Associated with Increased Productivity in the Workplace and at Home in Psoriatic Arthritis Patients Treated with Certolizumab Pegol

    Nov 1, 2015, 00:00
  • Current Clinical Practice Correspondence With Treatment Guidelines In Patients With Type 2 Diabetes Mellitus

    Nov 1, 2015, 00:00
  • A New Cost-Effectiveness Modelling Approach In Chronic Heart Failure With Reduced Ejection Fraction

    Nov 1, 2015, 00:00
  • Development and Validation of a Questionnaire Assessing the fears and Beliefs of Patients Suffering from Chronic Rheumatic Diseases

    Nov 1, 2015, 00:00
  • Pharmacoeconomic Analysis- Analysis Of Cost-Effectiveness Of Lanthanum-Carbonate (Lc) In Uncontrolled Hyperphosphatemia In Dialysis

    Nov 1, 2015, 00:00
  • The Use of Real World Evidence to Influence Practi A Systematic Review of Cprd Studies In English Guidances And Guidelines

    Nov 1, 2015, 00:00
  • Budgetary Implications Of Introducing The Gsk Ellipta Portfolio For Copd In The Uk

    Nov 1, 2015, 00:00
  • Real World Skin Clearance Rates for Biologic Treatments In Patients With Moderate to Severe Plaque Psoriasis- Interim Results From A Large Prospective, Observational Study

    Nov 1, 2015, 00:00
  • Best Practices for Network Meta-Analysis Methodology- Comparative Effectiveness of Interferon-Beta Therapies In Relapsing-Remitting Multiple Sclerosis

    Nov 1, 2015, 00:00
  • Economic Evaluation of Second Line Oral Antidiabetics for Type 2 Diabetes in Colombia

    Nov 1, 2015, 00:00
  • Beliefs About Medicines In An Urban Community Health Center Hypertension Population

    Nov 1, 2015, 00:00
  • Profile of Colorectal Cancer Treatment Within The Brazilian Public Setting- Analysis Of Datasus Aq Database

    Nov 1, 2015, 00:00
  • Direct And Indirect Costs Associated to Retinal Vascular Diseases In Italy. A Probabilistic Cost of Illness Study

    Nov 1, 2015, 00:00
  • Calibration of Piecewise Markov Models Using a Change-Point Analysis Through an Iterative Convex Optimization Algorithm

    Nov 1, 2015, 00:00
  • Evaluation of Who/Inrud Prescribing Indicators and Prescribing Trend of Antibiotics in Accidents and Emergency Department, Bahawal Victoria Hospital, Bahawalpur, Pakistan

    Nov 1, 2015, 00:00
  • A Systematic Review and Taxonomy of Economic Evaluations of Pharmaceuticals Licensed on The Basis of Uncontrolled Clinical Studies

    Nov 1, 2015, 00:00
  • Potential For Cost Savings Associated With A Novel Ibs Blood Panel For Diagnosing Diarrhea Predominant Irritable Bowel Syndrome (Ibs-D)- Italian Perspective

    Nov 1, 2015, 00:00
  • Health State Utilities Associated With Attributes of Weekly Injection Devices for Treatment of Type 2 Diabetes

    Nov 1, 2015, 00:00
  • Impact of Blood Transfusions on Hospital Length of Stay and Mortality- A Single-Center Experience

    Nov 1, 2015, 00:00
  • The Addition Of A Novel Colonoscope Device Improves Adenoma Detection In A German Screening Population Which May Result In Cost Savings Due To Fewer Cases Of Colorectal Cancer

    Nov 1, 2015, 00:00
  • Re-Evaluating The Cost-Effectiveness of Screening For Congenital Adrenal Hyperplasia (Cah)- The Sensitivity to Choice of Distributions In Probabilistic Sensitivity Analyses (Psas)

    Nov 1, 2015, 00:00
  • Comparative Analysis of Expenditure of Drugs for Malignancy

    Nov 1, 2015, 00:00
  • Treatment Costs and Patterns In Patients With Multiple Sclerosis Treated With Prolonged-Release Fampridine In Germany

    Nov 1, 2015, 00:00
  • Payer Vs. Industry Views on Managed Entry Agreements

    Nov 1, 2015, 00:00
  • Cost Offsets Associated With Rebif Use In First-Line Rrms- An Analysis Based on The Cochrane Collaboration Review And Real-World Persistence Data

    Nov 1, 2015, 00:00
  • Methodological Changes In Burden of Infectious Disease Estimation- The Case of Pneumococcal Infection In Colombia

    Nov 1, 2015, 00:00
  • Can Data Simulation Help Evaluate Hta Outcomes Over Time and Facilitate Early Decision-Making? a Case Study of Ticagrelor in Acute Coronary Syndrome in the Uk

    Nov 1, 2015, 00:00
  • Patient-Reported Outcomes within Health Technology Assessment Decision Making- Current Status and Implications for Future Policy

    Nov 1, 2015, 00:00
  • Burden Of Residual Skin and Joint Disease in Patients with Psoriatic Arthritis Treated with Biologics

    Nov 1, 2015, 00:00
  • Contrasting Model Predicted Life Expectancy In Patients With Type 2 Diabetes Across Different Mortality Risk Prediction Models Versus Data From The Canadian Chronic Disease Surveillance System

    Nov 1, 2015, 00:00
  • The impact of the u.s. Odac decision on avastin prescribing for metastatic breast cancer

    Nov 1, 2015, 00:00
  • Evaluating the Safety Impact of Light Emitting Diode (LED) Guided Drug Picking in an Outpatient Pharmacy

    Nov 1, 2015, 00:00
  • Psychometric Analysis And Validation of The Patient Satisfaction With Orthopaedic And Prosthetic Medical Devices, Modul Client Satisfaction With Device (Csd)

    Nov 1, 2015, 00:00
  • Results of the Eq-5d-3l Valuation Project for Ireland

    Nov 1, 2015, 00:00
  • Mapping of the 16-Item Sort form Version of the Menopause Cervantes Health-Related-Quality-of-Life Scale onto the Eq-5d-3l

    Nov 1, 2015, 00:00
  • What does Copd Exacerbation Means for Patients and for Healthcare?

    Nov 1, 2015, 00:00
  • A Systematic Review To Assess The Association Between The Use Of Antidepressants And Male-Only Cancers

    Nov 1, 2015, 00:00
  • Societal Burden And Impact On Health Related Quality Of Life (Hrqol) Of Non-Small Cell Lung Cancer (Nsclc) In Europe

    Nov 1, 2015, 00:00
  • Diareg - Diabetes Register Including Patient Reported Outcomes

    Nov 1, 2015, 00:00
  • Mortality Due To Cardiovascular Disease In Colombia, 1998-2011

    Nov 1, 2015, 00:00
  • Vedolizumab In Ulcerative Colitis; A Budget Impact Model for A Novel Drug In A Recession Environment

    Nov 1, 2015, 00:00
  • Cost-Effectiveness Analysis For Cervical Cancer Screening Using Hpv Tests In Brazil

    Nov 1, 2015, 00:00
  • Cost-Effectiveness of Pasireotide Long-Acting in a Treatment of Acromegaly in Finland. Economic Evaluation Based on Finnish Auria Biobank Data on Health Care Resource Utilization

    Nov 1, 2015, 00:00
  • A Comparison of Market Access Evaluations for Type Ii Diabetes Mellitus In France and Germany- An Analysis Using The Prismaccess Database

    Nov 1, 2015, 00:00
  • A Physician-Centered Intervention To Improve Control of Blood Pressure- Systematic Review And Meta-Analysis

    Nov 1, 2015, 00:00
  • Investigating The Impact of Contemporary Risk Factors for Diabetes Complications and Their Evolution on Risk Prediction Using The Ukpds 82 Equations

    Nov 1, 2015, 00:00
  • Medical Devices For Patients With Incontinence. Cost And Quantity Characteristics In Slovakia 2009 - 2013

    Nov 1, 2015, 00:00
  • Public Health and Economic Impact of 13-Valent Pneumococcal Conjugate Vaccine (Pcv13) in Public and Private System Versus Ppsv23 and No Vaccination in Older Adults

    Nov 1, 2015, 00:00
  • Preliminary Outcomes of Health-Related Quality of Life in Hiv-Infected Naïve Patients

    Nov 1, 2015, 00:00
  • Prevalnce of Cigrate Smooking And Allied Tobacco Products Among Universty Students In Quetta, Pakistan

    Nov 1, 2015, 00:00
  • Model-Based Techniques In The Early Phases of The Medical Device Development- A Systematic Literature Review

    Nov 1, 2015, 00:00
  • Cost-Utility of Certolizumab Pegol for The Treatment of Axial Spondyloarthritis In Greece

    Nov 1, 2015, 00:00
  • Simpson’s Paradox- Why Smoking Reduces the Risk of Dying of Cardiovascular Disease

    Nov 1, 2015, 00:00
  • Cost-Effectiveness of Ombitasvir/Paritaprevir/Ritonavir and Dasabuvir for Patients With Chronic Hcv in the Netherlands

    Nov 1, 2015, 00:00
  • Costs of Relapse of Schizophrenia for the Argentinian Health System

    Nov 1, 2015, 00:00
  • Estimation of Direct Medical Costs Associated with Treatment of Metastatic Melanoma in Switzerland

    Nov 1, 2015, 00:00
  • The Burden of Cancer in Emerging Economies- Productivity Loss as an Alternative Perspective

    Nov 1, 2015, 00:00
  • Cost-Utility Analysis of Adalimumab for The Treatment of Moderate-To-Severe Ulcerative Colitis In Patients In Spain

    Nov 1, 2015, 00:00
  • Impact of Clerkship Attachments on Students’ Attitude Towards Pharmaceutical Care In Ethiopia

    Nov 1, 2015, 00:00
  • «
  • 81 (current)
  • 82
  • 83
  • 84
  • 85
  • 86
  • 87
  • 88
  • 89
  • 90
  • »